Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Oct 2026 for X4 Pharmaceuticals, Inc, €11k.
Filing timeline
BuySaleAdam R. Craig
Insider track record
Disclosed buys
3
Disclosed sells
1
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -4.7%Entry US$3.81 · Close at T+90 US$3.63
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Adam R. Craig: trading record in brief
Adam R. Craig is a declared insider at 2 companies (chief executive); the most frequent names are CTI Biopharma Corp and X4 Pharmaceuticals, Inc. The record holds 14 filings, for trades running from 30 June 2021 to 16 October 2026.
Market trades split into 3 purchases (€253k) and 1 sale (€183k). Taken together, the purchases exceed the sales by €70k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants and 5 option exercises. In 2026 alone, the filings show 1 purchase and 1 sale.
In size, the median ticket on the buying side is €27k.
On 19 October 2026 came the latest disclosure, an open-market purchase for €11k in X4 Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Adam R. Craig
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
4,600 shares@ US$2.5834Common StockSEC:0001339498-26-000005:0
Canonical exit: 14 Jan 2027 (T+90)
47,436 shares@ US$4.44450.070% mcap45.9% of flowCommon StockSEC:0001501697-26-000069:0
86,206 shares@ US$2.9054.1% of flowCommon StockSEC:0001501697-25-000035:0
Canonical exit: 21 Jan 2026 (T+90)
289,881 shares0Common StockSEC:0001628280-25-040441:0
31,470 shares@ US$9.1039.8% of flowCommon StockSEC:0000899243-23-016480:0
83,200 shares@ US$0.84119.8% of flowcommon stockSEC:0000891293-23-000004:0
13,800 shares@ US$0.84111.7% of flowcommon stockSEC:0000891293-23-000002:0
53,996 shares@ US$0.84116.8% of flowcommon stockSEC:0000891293-22-000056:0
242,300 shares@ US$0.841130.5% of flowCommon StockSEC:0000899243-22-031043:0
5,000 shares@ US$5.504.1% of flowcommon stockSEC:0000891293-22-000044:0
Canonical exit: 14 Nov 2022 (T+90)
6,183 shares@ US$2.11651.9% of flowcommon stockSEC:0000891293-22-000034:0
27,000 shares@ US$0.84113.2% of flowcommon stockSEC:0000891293-22-000027:0
3,178 shares@ US$2.1080.9% of flowCommon StockSEC:0000899243-22-010768:0
5,000 shares@ US$2.1251.4% of flowcommon stockSEC:0000891293-21-000045:0
14 of 14 declarations
